Decheng Capital China Life Sciences USD Fund III, L.P.

Insider Reports History

Entity
Company
Location
Ugland House, Po Box 309, Grand Cayman, Cayman Islands
Signature
Decheng Capital China Life Sciences USD Fund III, L.P., By Decheng Capital Management III (Cayman), LLC, its General Partner, By /s/ Xiangmin Cui, Manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Decheng Capital China Life Sciences USD Fund III, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALPINE IMMUNE SCIENCES, INC. 10%+ Owner Common Stock 6,582,380 $83.9 M $12.74 Jan 18, 2024 Direct
Cue Health Inc. 10%+ Owner Common Stock 8,192,468 $2.46 M $0.30 Sep 28, 2021 Direct
ALPINE IMMUNE SCIENCES, INC. 10%+ Owner Warrant (right to buy) 0 Jan 18, 2024 Direct
Cue Health Inc. 10%+ Owner Series C-1 Preferred Stock 0 Sep 28, 2021 Direct

Insider Reports Filed by Decheng Capital China Life Sciences USD Fund III, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALPN ALPINE IMMUNE SCIENCES, INC. Jan 18, 2024 2 15,729,263 4 Jan 22, 2024 10%+ Owner
ALPN ALPINE IMMUNE SCIENCES, INC. Sep 23, 2022 2 14,700,000 4 Sep 27, 2022 10%+ Owner
HLTH Cue Health Inc. Sep 28, 2021 2 0 4 Sep 30, 2021 10%+ Owner
HLTH Cue Health Inc. Sep 23, 2021 0 0 3 Sep 23, 2021 10%+ Owner
ALPN ALPINE IMMUNE SCIENCES, INC. Sep 17, 2021 1 14,499,998 4 Sep 21, 2021 10%+ Owner